Psychedelics Division

// PSYCHEDELIC MEDICINE

Psychedelic Assets

Serenus Global is poised to capitalize on the expanding psychedelics market leveraging its 100% ownership of Conscious Compounds. Conscious Compounds is a Controlled Substances Dealers license holder that allows for the research, development, and production of controlled substances such as psilocybin and psilocin.

Conscious Compounds is currently producing psychedelic mushrooms at its 3250 ft² licensed facility.


Conscious
Compounds

Conscious Compounds is currently producing psychedelic mushrooms at its 3250 ft² licensed facility.

Facility contains FDA & CFIA-approved building materials.

Genetic library undergoing classification. Nearly 100 unique psilocybin-containing varieties.

First International export expected Q2-2023.

// FACILITIES

Conscious Compounds

Conscious Compounds is Serenus’ wholly owned Controlled Substances Dealers License holder in Canada with 2 unique facilities. Conscious Compounds has discrete locations, FDA & CFIA approved building materials, CCTV cameras, storage safes vaults and security cages to ensure staff and product protection.

Conscious Compounds is currently producing psychedelic mushrooms at its 3250 ft² licensed facility and providing starting material solutions for organic controlled substances.

  • Obtained for psilocybin and psilocin Q3-2022
  • 2nd Controlled Substance Dealers License application submitted Q1-2022
  • Off-take LOI in place for dried psychedelic mushrooms
  • Application approved by Health Canada (2nd facility currently under review stage with Health Canada)
// PSYCHEDELIC NEWS

Related News
& Stories

Uncover the latest developments and profound narratives in the realm of psychedelics. Learn about captivating news and global legislative changes in this rapidly expanding industry.

‘Shrooms go Upscale Amid Psychedelics Craze

(CN) — Joe Hudak struggled with his return to civilian life. The 47-year-old veteran spent 20 years in the special forces, including around five years in Iraq and Afghanistan.  After returning to the U.S. in 2011, he tried to kill himself twice — landing him a stint...

Rick Perry: The Conservative Case for Psychedelics

In June, I traveled to Denver with Zach Weismueller to cover the Psychedelic Science 2023 conference, organized by the Multidisciplinary Association for Psychedelic Studies (MAPS), a group that has been working to gain Food and Drug Administration approval of...